Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scancell develops apoptosis-inducing and anti-growth factor antibodies

Feb. 25, 2002

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Feb. 19, 2002

Hollis-Eden collaborating on development of Aeson's lead compound

Feb. 19, 2002

Compounds that enhance transcription factor AP-1 designed at Active Biotech

Feb. 18, 2002

Phase II trial of CeaVac and TriAb initiated in metastatic colorectal cancer

Feb. 12, 2002

Biomira initiates phase II trial of Theratope vaccine in metastatic colorectal cancer

Feb. 11, 2002

SciClone updates progress of Zadaxin

Feb. 11, 2002

MCA approves phase II study of TTS in pancreatic cancer

Feb. 7, 2002

Fast track designation for Oncophage in metastatic melanoma

Feb. 6, 2002

AltaRex offers further analysis of OvaRex results

Feb. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...